Results 201 to 210 of about 49,566 (218)

Hepatitis B vaccine alone may be enough for preventing hepatitis B virus transmission in neonates of HBsAg (+)/HBeAg (-) mothers.

Vaccine, 2017
Ying Lu, Xiaofeng Liang, Fu-zhen Wang, Ling Yan, Rong-cheng Li, Yan-ping Li, F. Zhu, X. Zhai, Jie Li, Z. Hui   +9 more
semanticscholar   +1 more source

Long-Term Follow-up of HBeAg-Positive Patients Treated with Interferon Alfa for Chronic Hepatitis B

New England Journal of Medicine, 1996
Dieter Häussinger
exaly  

Kinetics of serum HBsAg and intrahepatic cccDNA during pegylated interferon therapy in patients with HBeAg‐positive and HBeAg‐negative chronic hepatitis B

Journal of Medical Virology, 2017
N. Chuaypen, Methee Sriprapun, K. Praianantathavorn, S. Payungporn, N. Wisedopas, Y. Poovorawan, P. Tangkijvanich   +6 more
semanticscholar   +1 more source

Long-Term Therapy with Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B

New England Journal of Medicine, 2005
Seng Gee Lim, Zachary Goodman
exaly  

Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma

Journal of Hepatology, 2007
Shi-Ming Lin, Ming-Lung Yu, Y-F Liaw
exaly  

Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B).

Journal of Hepatology, 2016
H. Chan, S. Ahn, Ting Chang, C. Peng, D. Wong, C. Coffin, S. Lim, Pei‐Jer Chen, H. Janssen, P. Marcellin, L. Serfaty, S. Zeuzem, David Cohen, L. Critelli, Dong Xu, M. Wind-Rotolo, E. Cooney   +16 more
semanticscholar   +1 more source

Serum hepatitis B core‐related antigen as a treatment predictor of pegylated interferon in patients with HBeAg‐positive chronic hepatitis B

Liver international (Print), 2016
N. Chuaypen, Nawarat Posuwan, S. Payungporn, Yasuhito Tanaka, N. Shinkai, Y. Poovorawan, P. Tangkijvanich   +6 more
semanticscholar   +1 more source

HBeAg seroconversion as an important end point in the treatment of chronic hepatitis B

Hepatology International, 2009
Y-F Liaw
exaly  

Sustained Immune Control in HBeAg-Positive Patients who Switched from Entecavir Therapy to Pegylated Interferon-α2a: 1 Year follow-up of the OSST Study

Antiviral Therapy, 2016
Meifang Han, Jiaji Jiang, J. Hou, D. Tan, Yongtao Sun, M. Zhao, Q. Ning   +6 more
semanticscholar   +1 more source

Follow-up and indications for liver biopsy in HBeAg-negative chronic hepatitis B virus infection with persistently normal ALT: A systematic review

Journal of Hepatology, 2012
Spilios Manolakopoulos, Y-F Liaw, Anna Lok   +2 more
exaly